semaglutide and glp 1 Comparing Ozempic, Wegovy Other GLP-1 Drugs GLP-1 Weight Loss Options |

Retatrutide is an investigational peptide drug developed by Eli Lilly that acts as a triple agonist, simultaneously targeting three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors

Tirzepatide - subcutaneous route

doi:10.1111/acer.13559 Mintz CM, Hartz SM, Fisher SL, et al

Some, like the digestive symptoms, are more common 15 than others and may only be short-term as the body adjusts: Thyroid cancer risk factor: The risk of thyroid cancer was seen in an animal study and not necessarily in people, but nonetheless, it is a risk you should be made aware of

The key is to plan ahead

What to Expect: Timeline of Results Understanding the typical progression of benefits helps set realistic expectations and maintain motivation through the early stages of treatment